Mucormycosis is a life-threatening opportunistic infection caused by the fungi belonging to the order Mucorales. Mucormycosis commonly develops in patients with diabetes mellitus having a background of immunosuppression. An integrative approach in the management of COVID-19-associated mucormycosis can be more effective and beneficial to the patients, as the delay in diagnosis and treatment is commonly associated with COVID-19. The rehabilitation of the resected facial structures in these patients would be very crucial in sustaining the quality of life. Thus, our review aims in providing insights into management strategies across different fields of medicine and the various rehabilitation methods.

Original languageEnglish
Pages (from-to)S120-S123
JournalJournal of Datta Meghe Institute of Medical Sciences University
Issue number5
Publication statusPublished - 08-2022

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Integrated treatment strategies and prosthetic rehabilitation for COVID-19-associated mucormycosis'. Together they form a unique fingerprint.

Cite this